Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced the company will partner with Mylan N.V. (NASDAQ:MYL) to commercialize FKB327, a biosimilar to Humira (adalimumab) developed by Fujifilm... read more
Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced the company will partner with Mylan N.V. (NASDAQ:MYL) to commercialize FKB327, a biosimilar to Humira (adalimumab) developed by Fujifilm... read more
Nektar Therapeutics (Nasdaq: NKTR) today announced that it has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and safety of the combination of... read more
Quadrant Biosciences announced today the execution of three licensing agreements with SUNY Upstate Medical University and Penn State University for the global commercialization of epigenetic... read more
Pfizer announced today that the independent Data Monitoring Committee for the Phase 3 ATLAS trial evaluating Inlyta The study failing to demonstrate a clear improvement in the primary endpoint of... read more
Mylan and Mapi Pharma announced today that the two companies will partner on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,